Shanghai Pharmaceutical Co Ltd (601607):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Pharmaceutical Co Ltd (601607) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1129
◆発行会社(調査会社):GlobalData
◆発行日:2020年2月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai Pharmaceutical Co Ltd (601607) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler, and distributor of healthcare products. The company carries out the researches, develops, produces, and sells pharmaceutical products for the treatment of HER2 positive advanced breast cancer, systemic anti-infection, and antineoplastic drug and immunomodulator. It also offers medicines for diseases and disorders of cardiovascular system, digestive and metabolism, neurological system, musculoskeletal system, and respiratory system. Shanghai Pharma also provides traditional Chinese medicines. It provides distribution and supply chain solutions to pharmaceutical manufacturers and dispensers; operates retail pharmacy stores; and provides consulting services, assets management and other services. The company operates through its subsidiaries in China. Shanghai Pharma is headquartered in Shanghai, China.

Shanghai Pharmaceutical Co Ltd Key Recent Developments

Sep 30,2019: Shanghai Pharma Global Standard Stock Incentive Scheme to push innovation refiled for approval

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Shanghai Pharmaceutical Co Ltd – Key Facts
Shanghai Pharmaceutical Co Ltd – Key Employees
Shanghai Pharmaceutical Co Ltd – Key Employee Biographies
Shanghai Pharmaceutical Co Ltd – Major Products and Services
Shanghai Pharmaceutical Co Ltd – History
Shanghai Pharmaceutical Co Ltd – Company Statement
Shanghai Pharmaceutical Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Shanghai Pharmaceutical Co Ltd – Business Description
Business Segment: Distribution and Supply Chain Solutions
Overview
Performance
Business Segment: Other Business Operations
Overview
Performance
Business Segment: Pharmaceutical Business
Overview
Performance
Business Segment: Pharmaceutical Retail
Overview
Performance
Key Stats
R&D Overview
Shanghai Pharmaceutical Co Ltd – Corporate Strategy
Shanghai Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Pharmaceutical Co Ltd – Strengths
Shanghai Pharmaceutical Co Ltd – Weaknesses
Shanghai Pharmaceutical Co Ltd – Opportunities
Shanghai Pharmaceutical Co Ltd – Threats
Shanghai Pharmaceutical Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 30, 2019: Shanghai Pharma Global Standard Stock Incentive Scheme to push innovation refiled for approval
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Shanghai Pharmaceutical Co Ltd, Key Facts
Shanghai Pharmaceutical Co Ltd, Key Employees
Shanghai Pharmaceutical Co Ltd, Key Employee Biographies
Shanghai Pharmaceutical Co Ltd, Major Products and Services
Shanghai Pharmaceutical Co Ltd, History
Shanghai Pharmaceutical Co Ltd, Subsidiaries
Shanghai Pharmaceutical Co Ltd, Affiliate
Shanghai Pharmaceutical Co Ltd, Key Competitors
Shanghai Pharmaceutical Co Ltd, Ratios based on current share price
Shanghai Pharmaceutical Co Ltd, Annual Ratios
Shanghai Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Shanghai Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Shanghai Pharmaceutical Co Ltd, Interim Ratios
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Shanghai Pharmaceutical Co Ltd, Performance Chart (2014 - 2018)
Shanghai Pharmaceutical Co Ltd, Ratio Charts
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Shanghai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Shanghai Pharmaceutical Co Ltd (601607):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Henkel AG & Co. KGaA:企業のM&A・事業提携・投資動向
    Henkel AG & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henkel AG & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Covanta Holding Corporation (CVA):電力:M&Aディール及び事業提携情報
    Summary Covanta Holding Corporation (Covanta) is a provider of sustainable waste and energy solutions. It generates electricity from its Energy-from-Waste (EfW); and recycles ferrous and non-ferrous metals through its subsidiaries. Its Energy-from-Waste (EfW) facilities convert more than 20 million …
  • Electricite de France (EDF):戦略・SWOT・企業財務分析
    Electricite de France (EDF) - Strategy, SWOT and Corporate Finance Report Summary Electricite de France (EDF) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • LifePoint Health:企業の戦略・SWOT・財務情報
    LifePoint Health - Strategy, SWOT and Corporate Finance Report Summary LifePoint Health - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ViaCord LLC:企業の戦略的SWOT分析
    ViaCord LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Logibec Groupe Informatique Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Logibec Groupe Informatique Ltd (Logibec), a subsidiary of GI Partners LLC, is a technology company that develops, markets, implements and supports clinical and administrative information systems. The company offers administrative solutions include Espresso FMS and MMS, an integrated informa …
  • Luzerner Kantonalbank AG:企業の戦略・SWOT・財務分析
    Luzerner Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Luzerner Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務情報
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Animal Husbandry Industry Co Ltd (600195):企業の財務・戦略的SWOT分析
    China Animal Husbandry Industry Co Ltd (600195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • PT Elnusa Tbk (ELSA):企業の財務・戦略的SWOT分析
    Summary PT Elnusa Tbk (PT Elnusa), a subsidiary of PT Pertamina (Persero), is an oil and gas company that offers geo science services, and drilling and oilfield services. The company's geo science services include seismic data acquisition, seismic data measurement, seismic data processing, and non s …
  • Church & Dwight Co Inc:企業の戦略・SWOT・財務情報
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Club Mediterranee SA:戦略・SWOT・企業財務分析
    Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report Summary Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arthrex Inc:企業の戦略的SWOT分析
    Arthrex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • DocCheck AG (AJ91):企業の財務・戦略的SWOT分析
    DocCheck AG (AJ91) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cargolux Airlines International SA:企業の戦略的SWOT分析
    Cargolux Airlines International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • BrightSpring Health Services:企業の戦略的SWOT分析
    BrightSpring Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • China Construction Bank Corp:企業の戦略・SWOT・財務情報
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆